Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilson Tang

Showing results (251-260 of 1,044) with videos related to

Pageof 105
Sort By:
Current Treatment Options in Cardiovascular Medicine|June 28, 2021
Invasive Hemodynamic and Metabolic Evaluation of HFpEFJ Emanuel Finet, Erik H Van Iterson, W H Wilson Tang
Mayo Clinic Proceedings|August 2, 2024
Self-Reported Sodium Intake and Sodium Vulnerability in Heart Failure With Preserved Ejection FractionPieter Martens, Wilfried Mullens, James C Fang, et al.
Journal of Personalized Medicine|June 28, 2023
Genetic Evaluation and Screening in Cardiomyopathies: Opportunities and Challenges for Personalized MedicineSahana Aiyer, Emilia Kalutskaya, Arianne C Agdamag, et al.
The American Journal of Cardiology|December 17, 2023
Spontaneous Improvement in Iron Parameters and the Relation With Changes in Functionality in Heart FailurePieter Martens, Gregory D Lewis, Wilfried Mullens, et al.
Current Treatment Options in Cardiovascular Medicine|August 28, 2016
Practical Pharmacogenomic Approaches to Heart Failure TherapeuticsChayakrit Krittanawong, Amalia Namath, David E Lanfear, et al.
Circulation. Heart Failure|August 18, 2012
Cystatin C identifies patients with stable chronic heart failure at increased risk for adverse cardiovascular eventsMatthias Dupont, Yuping Wu, Stanley L Hazen, et al.
The American Journal of Cardiology|December 11, 2012
Usefulness of cardiac biomarker score for risk stratification in stable patients undergoing elective cardiac evaluation across glycemic statusW H Wilson Tang, Naveed Iqbal, Yuping Wu, et al.
JACC. Heart Failure|December 9, 2023
Meta-Analysis and Metaregression of the Treatment Effect of Intravenous Iron in Iron-Deficient Heart FailurePieter Martens, Silvio Nunes Augusto, Wilfried Mullens, et al.
JACC. Heart Failure|November 9, 2023
30- and 60-Day Readmission Rates for Children With Heart Failure in the United StatesShahnawaz Amdani, Rocio Lopez, Jesse D Schold, et al.
Current Heart Failure Reports|October 17, 2015
Evolving Approaches to Genetic Evaluation of Specific CardiomyopathiesLoon Yee Louis Teo, Rocio T Moran, W H Wilson Tang
Pageof 105

Showing results (251-260 of 1,044) with videos related to

Sort By:
Pageof 105
Current Treatment Options in Cardiovascular Medicine|June 28, 2021
Invasive Hemodynamic and Metabolic Evaluation of HFpEFJ Emanuel Finet, Erik H Van Iterson, W H Wilson Tang
Mayo Clinic Proceedings|August 2, 2024
Self-Reported Sodium Intake and Sodium Vulnerability in Heart Failure With Preserved Ejection FractionPieter Martens, Wilfried Mullens, James C Fang, et al.
Journal of Personalized Medicine|June 28, 2023
Genetic Evaluation and Screening in Cardiomyopathies: Opportunities and Challenges for Personalized MedicineSahana Aiyer, Emilia Kalutskaya, Arianne C Agdamag, et al.
The American Journal of Cardiology|December 17, 2023
Spontaneous Improvement in Iron Parameters and the Relation With Changes in Functionality in Heart FailurePieter Martens, Gregory D Lewis, Wilfried Mullens, et al.
Current Treatment Options in Cardiovascular Medicine|August 28, 2016
Practical Pharmacogenomic Approaches to Heart Failure TherapeuticsChayakrit Krittanawong, Amalia Namath, David E Lanfear, et al.
Circulation. Heart Failure|August 18, 2012
Cystatin C identifies patients with stable chronic heart failure at increased risk for adverse cardiovascular eventsMatthias Dupont, Yuping Wu, Stanley L Hazen, et al.
The American Journal of Cardiology|December 11, 2012
Usefulness of cardiac biomarker score for risk stratification in stable patients undergoing elective cardiac evaluation across glycemic statusW H Wilson Tang, Naveed Iqbal, Yuping Wu, et al.
JACC. Heart Failure|December 9, 2023
Meta-Analysis and Metaregression of the Treatment Effect of Intravenous Iron in Iron-Deficient Heart FailurePieter Martens, Silvio Nunes Augusto, Wilfried Mullens, et al.
JACC. Heart Failure|November 9, 2023
30- and 60-Day Readmission Rates for Children With Heart Failure in the United StatesShahnawaz Amdani, Rocio Lopez, Jesse D Schold, et al.
Current Heart Failure Reports|October 17, 2015
Evolving Approaches to Genetic Evaluation of Specific CardiomyopathiesLoon Yee Louis Teo, Rocio T Moran, W H Wilson Tang
Pageof 105